Skip to main navigation Skip to search Skip to main content

The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia.

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)890-891
Number of pages2
JournalLeukemia
Volume2010
Publication statusPublished - 2010

Keywords

  • cll

Cite this